Form 8-K - Current report:
SEC Accession No. 0001193125-22-177791
Filing Date
2022-06-21
Accepted
2022-06-21 17:24:57
Documents
12
Period of Report
2022-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d367101d8k.htm   iXBRL 8-K 48125
  Complete submission text file 0001193125-22-177791.txt   167467

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA biib-20220615.xsd EX-101.SCH 2867
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20220615_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20220615_pre.xml EX-101.PRE 10820
6 EXTRACTED XBRL INSTANCE DOCUMENT d367101d8k_htm.xml XML 3204
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 221029152
SIC: 2836 Biological Products, (No Diagnostic Substances)